About RayThera
RayThera is a company based in San Diego (United States) founded in 2023 by Gene Hung and Qing Dong was acquired by Biogen in June 2026. RayThera has raised $110 million across 1 funding round from investors including Biogen, Orbimed and Foresite Capital. RayThera offers products and services including Small Molecule Therapies and Innovative Drug Solutions.
- Headquarter San Diego, United States
- Founders Gene Hung, Qing Dong
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Raythera, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RayThera
RayThera offers a comprehensive portfolio of products and services, including Small Molecule Therapies and Innovative Drug Solutions.
Small molecule therapies are developed for critical unmet needs in immunology, with an emphasis on accelerating the process while upholding rigorous standards.
Innovative drug solutions are provided that aim to transform patient care through adaptable approaches in drug discovery.
Funding Insights of RayThera
RayThera has successfully raised a total of $110M through 1 strategic funding round. The most recent funding activity was a Series A round of $110 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in RayThera
RayThera has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Biogen, Orbimed and Foresite Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Locked | Locked | Locked | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
A leading Chinese venture capital firm in healthcare is operated.
|
Locked | Locked | Locked |
Investor details for RayThera
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RayThera
Investment portfolio details for RayThera
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RayThera
Detailed financials for RayThera
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Raythera Comparisons
Peer comparison for RayThera
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RayThera
Detailed competitors of RayThera
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Raythera
Complete news archive for RayThera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RayThera
RayThera was founded in 2023 and raised its 1st funding round 2 years after it was founded.
RayThera is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Qing Dong is the current CEO of RayThera. They have also founded this company.
RayThera is a funded company, having raised a total of $110M across 1 funding round to date.
RayThera was founded in 2023 and is based in San Diego, United States. Operations center on drug discovery in the immunology sector, where small molecule therapies are advanced to address unmet medical needs. Expertise is applied to accelerate development while standards are upheld. Transformative treatments are pursued to enhance patient outcomes in immunology.
RayThera offers Small Molecule Therapies and Innovative Drug Solutions.
RayThera has 4 investors. Key investors include Biogen, Orbimed, Foresite Capital, and TTM Capital.